(Translated by https://www.hiragana.jp/)
Adenine phosphoribosyltransferase: Difference between revisions - Wikipedia Jump to content

Adenine phosphoribosyltransferase: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Tags: Mobile edit Mobile app edit
→‎Further reading: 10.1007/978-1-4615-2584-4_137
Line 23: Line 23:
==Further reading==
==Further reading==
{{refbegin | 2}}
{{refbegin | 2}}
*{{cite journal | author=Tischfield JA, Engle SJ, Gupta PK |title=Germline and somatic mutation at the APRT locus of mice and man. |journal=Adv. Exp. Med. Biol. |volume=370 |issue= |pages= 661–4 |year= 1995 |pmid= 7660991 |doi= |display-authors=etal}}
*{{cite journal | author=Tischfield JA, Engle SJ, Gupta PK |title=Germline and somatic mutation at the APRT locus of mice and man. |journal=Adv. Exp. Med. Biol. |volume=370 |issue= |pages= 661–4 |year= 1995 |pmid= 7660991 |doi= 10.1007/978-1-4615-2584-4_137 |display-authors=etal}}
*{{cite journal | author=Takeuchi H, Kaneko Y, Fujita J, Yoshida O |title=A case of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0) leading to 2,8-dihydroxyadenine urolithiasis: review of the reported cases with 2,8-dihydroxyadenine stones in Japan. |journal=J. Urol. |volume=149 |issue= 4 |pages= 824–6 |year= 1993 |pmid= 8455250 |doi= }}
*{{cite journal | author=Takeuchi H, Kaneko Y, Fujita J, Yoshida O |title=A case of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0) leading to 2,8-dihydroxyadenine urolithiasis: review of the reported cases with 2,8-dihydroxyadenine stones in Japan. |journal=J. Urol. |volume=149 |issue= 4 |pages= 824–6 |year= 1993 |pmid= 8455250 |doi= }}
*{{cite journal | author=Ludwig H, Kuzmits R, Pietschmann H, Müller MM |title=Enzymes of the purine interconversion system in chronic lymphatic leukemia: decreased purine nucleoside phosphorylase and adenosine deaminase activity. |journal=Blut |volume=39 |issue= 5 |pages= 309–15 |year= 1980 |pmid= 116697 |doi=10.1007/BF01014193 }}
*{{cite journal | author=Ludwig H, Kuzmits R, Pietschmann H, Müller MM |title=Enzymes of the purine interconversion system in chronic lymphatic leukemia: decreased purine nucleoside phosphorylase and adenosine deaminase activity. |journal=Blut |volume=39 |issue= 5 |pages= 309–15 |year= 1980 |pmid= 116697 |doi=10.1007/BF01014193 }}

Revision as of 09:36, 23 August 2015

Template:PBB Adenine phosphoribosyltransferase is an enzyme that in humans is encoded by the APRT gene.[1]

Function

APRTase is an enzyme involved in the purine nucleotide salvage pathway. It functions as a catalyst in the reaction between adenine and phosphoribosyl pyrophosphate (PRPP) to form AMP.

APRT is functionally related to hypoxanthine-guanine phosphoribosyltransferase (HPRT).

Pathology

Deficiency purines APRT in human beings may lead to kidney stones formed of adenine and salts.

2,8-Dihydroxy-adenine urolithiasis is also known as "adenine phosphoribosyltransferase deficiency".

Adenine phosphoribosyltransferase (APRT) deficiency is an uncommon genetic disorder that often causes kidney stones, and in some patients kidney failure. More than 300 individuals with this disease have been reported world-wide but it is not known how common this medical problem truly is. Patients with the disease deficiency lack the enzyme adenine phosphoribosyltransferase and therefore have difficulties breaking down purines. This may result in the accumulation 2,8-dihydroxyadenine (2,8-DHA) that is excreted by the kidneys. 2,8-DHA is poorly soluble in the urine leads to the formation of kidney stones and kidney injury.[1]

Interestingly, up to 70% of affected patients, have red hair or relatives with this hair color.

References

  1. ^ a b "Entrez Gene: APRT adenine phosphoribosyltransferase".

Further reading